MedPath

Evaluation of clinical disintegration time and palatability of orally disintegrating tablets of rebamipide

Not Applicable
Conditions
Healhy volunteea
Registration Number
JPRN-UMIN000023380
Lead Sponsor
Hamamatsu University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1. clearly taste disorder 2. allegy for drugs 3. pregnant and/or lactating women 4. other who was decided as inadequate by doctor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath